0000899243-23-020117.txt : 20231102
0000899243-23-020117.hdr.sgml : 20231102
20231102205522
ACCESSION NUMBER: 0000899243-23-020117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231031
FILED AS OF DATE: 20231102
DATE AS OF CHANGE: 20231102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fairey William
CENTRAL INDEX KEY: 0001727275
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 231374210
MAIL ADDRESS:
STREET 1: C/O CHEMOCENTRYX, INC.
STREET 2: 850 MAUDE AVE.
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001420565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 738 MAIN STREET
STREET 2: UNIT 398
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-995-0900
MAIL ADDRESS:
STREET 1: 738 MAIN STREET
STREET 2: UNIT 398
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-10-31
0
0001420565
AILERON THERAPEUTICS INC
ALRN
0001727275
Fairey William
C/O AILERON THERAPEUTICS, INC.
738 MAIN STREET #398
WALTHAM
MA
02451
1
0
0
0
0
Stock Option (right to buy)
1.17
2023-10-31
4
A
0
5450
0.00
A
2033-10-30
Common Stock
5450
5450
D
This option was granted October 31, 2023. The shares underlying the option are scheduled to vest over 48 equal monthly installments from October 31, 2023, subject to continued service.
/s/ Manuel C. Alves-Aivado, M.D., Ph.D., as attorney-in-fact for William Fairey
2023-11-02